Abstract: We examined changes in federal sexually transmitted disease funding allocations to areas with high racial/ethnic disparities in sexually transmitted diseases after the implementation of a funding formula in 2014. The funding formula increased prevention funding allocations to areas with high relative racial/ethnic disparities. Results were mixed for areas with high absolute disparities.
R
acial and ethnic disparities in reported rates of chlamydia, gonorrhea, and syphilis have been documented and described extensively for decades. [1] [2] [3] [4] [5] Two key strategies have been suggested for sexually transmitted disease (STD) prevention programs to reduce these disparities. First, to the extent possible, STD prevention programs should contribute to collaborative public health efforts that address the social determinants of health that cause these racial/ethnic disparities in STDs and other health outcomes. 4 Second, and more specifically, STD prevention programs should focus their resources and services on the most affected populations and geographic areas where racial/ethnic disparities in STDs are most pronounced. [1] [2] [3] [4] For more than 50 years, the Division of STD Prevention (DSTDP) at the Centers for Disease Control and Prevention (CDC) has provided funding and other resources to numerous project areas for STD prevention activities. 6, 7 These project areas include all states, some territories, and some cities. Starting in 2014, DSTDP adopted a funding allocation formula in which a project area's allocation was based on population size and reported STD burden. 8 Specifically, the formula allocates 50% of funding based on the size of the population aged 15 to 44 years; 40% based on the total number of reported cases of chlamydia, gonorrhea, and primary and secondary syphilis; and 10% based on the rates of these 3 STDs among ages 15 to 44 years. Program activities required among funding recipients include conducting surveillance, monitoring screening rates, assessing gaps in STD prevention services, and increasing capacity to direct resources to populations most at risk. 8 The main objectives behind the institution of the funding formula included improvements in efficiency, equity, and transparency in the allocation of federal funds. The funding formula included burden of disease so that resources would be targeted to areas with greatest need, thereby increasing efficiency. However, a formula based only on burden could penalize high-achieving programs by decreasing funding to those who reduce their STD rates. Population was included in the funding formula to help reduce the potential for these unintended consequences and to ensure that minimum funding needs for STD prevention are met regardless of disease burden. 9 Decreasing racial and ethnic disparities in STDs is one of the main goals of DSTDP. 10 Although the funding formula implemented in 2014 by DSTDP does not explicitly include measures of racial/ethnic disparities in STDs in determining funding allocations, the funding formula does include STD case numbers and rates to target funding to areas where the burden of disease is the greatest. The purpose of this article was to assess the extent to which the introduction of the funding formula in 2014 affected the distribution of funds to project areas with the greatest racial/ ethnic disparities in STDs.
MATERIALS AND METHODS
Our basic approach was to examine STD funding allocations in the years before and after the implementation of the funding formula in 2014 and to calculate the percentage change in funding to areas with high racial/ethnic disparities in STDs. Data on STD cases and rates (cases per 100,000 population) from 2007 to 2016 were obtained from surveillance records maintained by CDC, as described in annual surveillance reports. 11 Data on annual funding allocations from 2012 to 2016 came from unpublished CDC records.
We calculated 4 disparity measures for each of 3 STDs: gonorrhea, (primary and secondary) syphilis, and chlamydia. The 4 disparity measures were as follows: (1) the non-Hispanic black (hereafter black) to non-Hispanic white (hereafter white) STD rate ratio, (2) the weighted index of disparity across 5 groups (black, white, Hispanic, Asian/Pacific Islander, and American Indian/Alaskan Native) using the overall STD rate as the reference group, 12 (3) the absolute difference in black and white STD rates, and (4) an absolute analog of the weighted index of disparity. Measures 1 and 3 focus on black-white disparity, whereas measures 2 and 4 examine disparity across 5 racial/ethnic groups. Measures 1 and 2 examine relative disparity, whereas measures 3 and 4 examine absolute disparity. Precise definitions of all disparity measures and example calculations are available in the supplemental online content (see Text, Supplemental Digital Content 1, http:// links.lww.com/OLQ/A264). For each disparity measure, a project area was defined as a high-disparity area if it had greater than the median disparity measure. We used 2007-2011 data to determine the high-disparity areas because these were the same years of data applied in the funding formula to determine funding allocations.
Annual funding data were first divided by population size and then normalized by dividing by the year-specific mean percapita funding rate across all project areas. For example, a project area whose per-capita funding was 20% higher than the mean percapita funding would have a normalized funding value of 1.2. Expressing funding in per capita terms allowed for comparisons across areas of different population sizes. Because our article focused on the distribution of funds to high-disparity areas, dividing each project area's per-capita funding in a given year by the mean per-capita funding across all project areas that year allowed for consistent comparisons of relative funding across years irrespective of decreases in overall funding over time.
Two normalized funding measures were calculated for each project area: the mean of the years before the funding formula implementation (2012 and 2013) and the mean of the years post implementation (2014-2016). Then the means of these preimplementation and postimplementation funding measures were taken across all high-disparity project areas. Finally, we calculated the percent change in funding before and after implementation of the funding formula for high-disparity project areas. A positive percent change indicated that relatively more funds were going to the high-disparity areas after the implementation of the funding formula in 2014 than before. Our main analysis focused on 57 project areas, including all 50 states and 7 cities: Baltimore, Chicago, Los Angeles, New York City, Philadelphia, San Francisco, and Washington, DC. In a secondary analysis, we excluded the 7 funded cities to focus only on the 50 states.
RESULTS
Funding for STD prevention allocated by CDC was $0.42 per capita in 2012 to 2013 and ranged from $0.15 to $2.33 across project areas. Figure 1 shows the percent change in funding to high-disparity project areas after the implementation of the funding formula in 2014. This change is presented for 4 disparity measures and 3 diseases: chlamydia, gonorrhea, and syphilis.
Using the relative disparity measures, funding increased to high-disparity areas for all 3 diseases after implementation of the funding formula. However, using the absolute disparity measures, funding to high-disparity measures decreased slightly after implementation, except for project areas with high black-to-white disparities in syphilis. The percent changes in funding to high-disparity areas were much larger when grouping project areas by relative disparity measures than when grouping by absolute disparity measures. For example, the percent increase in funding to areas with high relative gonorrhea disparity (all races) was 5%, whereas the percent decrease in funding to areas with high absolute gonorrhea disparity (all races) was 0.5%.
When the 7 metropolitan areas were excluded from the analysis, the implementation of the funding formula resulted in increases in funding to high-disparity areas received across all 4 disparity measures and all 3 STDs (see Figure 
DISCUSSION
This article investigates how the implementation of the funding formula in 2014 affected STD prevention funding allocations to areas with high racial/ethnic disparities in STDs. The funding formula led to increased prevention funding allocations for areas with high relative disparity, a result that held across all 3 STDs when considering black-white disparity or all-race disparity. For areas with high absolute disparity, the results were mixed. Funding to areas with high absolute disparity generally decreased slightly (by approximately 1% or less) when we included the 7 metropolitan areas in the analyses, but increased moderately (by approximately 1%-3%) when these metropolitan areas were excluded.
Metropolitan areas tend to have higher absolute and lower relative racial/ethnic disparities in STDs compared with nonmetropolitan areas, which likely explains the influence of metropolitan areas on the results. Because these metropolitan areas were generally also receiving higher-than-average per capita funding, they experienced larger funding decreases after the funding formula change. When excluding the 7 metropolitan areas from the analysis, the funding formula led to increased prevention funding allocations for areas with high absolute disparity, for all 3 STDs and when considering black-white disparity or all-race disparity.
Our analysis is subject to several limitations, in addition to the usual limitations associated with STD surveillance data. 11 For example, we did not consider every available disparity measure; instead, we focused on 4 measures for illustrative purposes. As our analyses demonstrated, different disparity measures can yield divergent results regarding the effect of the funding formula implementation. Our analysis focused only on federal STD prevention funds. We did not include state and local funds, nor did we consider the possibility that receipt of federal funds might affect funding from these other sources. Furthermore, our analysis simply documented changes in funding allocations across areas with high racial/ethnic disparity as a result of the funding formula that was instituted, and did not examine other possible resource allocation algorithms. A more detailed analysis of the optimality of the funding changes is beyond the scope of this article. Finally, our analysis focused on racial/ethnic disparities in STDs. Future studies could examine other disparities, such as among men who have sex with men versus heterosexual men.
Our key conclusion is that the application of the funding formula in 2014 can reduce racial/ethnic disparities in STDs by increasing prevention resources where they are most needed. That is, by most measures, the application of the funding formula in 2014 led to increases in STD prevention funding to areas with high racial/ethnic disparities in STDs, particularly for areas with high relative disparity. Although disparity is not a factor explicitly considered in the funding formula, the funding formula can help to address disparities by targeting resources to areas with the highest STD burden. Modifications to the funding formula to account explicitly for disparity would require careful consideration of the relationship between disease incidence and disparity, the choice of which disparity measure(s) to use, and other context-specific factors.
